Results 41 to 50 of about 1,420 (166)

Alopecia mucinosa responding to antileprosy treatment: Are we missing something?

open access: yesIndian Journal of Dermatology, 2013
Three cases with single lesion of Alopecia mucinosa (follicular mucinosis) were treated with antileprosy treatment and showed rapid and complete resolution of the lesions with no recurrence on extended follow-up.
Rajiv Joshi, Vinay Gopalani
doaj   +1 more source

Acral papular mucinosis: a new case of this rare entity [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2016
Acral persistent papular mucinosis (APPM) is a rare subtype of localized lichen myxedematosus. It consists of small papules localized exclusively on the back of the hands, wrists and extensor aspects of distal forearms with no other clinical or ...
María Encarnación Gómez Sánchez   +4 more
doaj   +1 more source

A Case of Peripheral Odontogenic Myxofibroma Arising in the Palatal Gingiva of the Maxillary Second Premolar Region: A Case Report

open access: yesCase Reports in Dentistry, Volume 2026, Issue 1, 2026.
Odontogenic myxofibroma (OMF) is a rare benign mesenchymal odontogenic tumor characterized by myxoid stroma with a prominent fibrous component. Although it usually arises intraosseously within the jaws, the peripheral variant, peripheral odontogenic myxofibroma (POMF), which occurs in extraosseous soft tissues, is uncommon and may be clinically ...
Masanori Masui   +4 more
wiley   +1 more source

Treatment of scleromyxedema Arndt-Gottron with a novel intravenous immunoglobulin preparation

open access: yesDermatology Reports
Dear Editor, Scleromyxedema is known as a rare, severe mucinosis with characteristic waxy skin papules along with sclerodermiform induration of the skin and rare systemic manifestations. Monoclonal gammopathy of undetermined significance (MGUS; mostly
Niklas Negele   +2 more
doaj   +1 more source

Successful Multimodal Therapeutic Approach for CD30‐positive Folliculotropic Mycosis Fungoides

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 8, Page e1123-e1125, August 2026.
Chiara L. Blomen   +5 more
wiley   +1 more source

Topical Imiquimod in Mycosis Fungoides: A Systematic Review of Published Clinical Evidence

open access: yesDermatologic Therapy, Volume 2026, Issue 1, 2026.
Background Topical imiquimod has been used as a skin‐directed treatment in selected patients with mycosis fungoides, but the available evidence remains limited and scattered across case reports, case series, pilot studies, retrospective cohorts, and preliminary conference data.
Kerem Balan   +2 more
wiley   +1 more source

Folliculotropic Mycosis Fungoides: Update on Diagnosis, Clinicopathological Stage, and Management

open access: yesDermatologic Therapy, Volume 2026, Issue 1, 2026.
Folliculotropic mycosis fungoides (FMF) is a rare subtype of MF, characterized by prominent folliculotropism in histopathology. Clinically, FMF exhibits polymorphic presentations, mainly including follicular papules, plaques, alopecia, and other nonspecific lesions, with a predilection for the head and neck region, leading to frequent misdiagnosis ...
Xingyu Li, Jie Liu, Nicola Pimpinelli
wiley   +1 more source

SCLEROMYXEDEMA [PDF]

open access: yesActa Medica Iranica, 1996
Scleromyxedema is a rare, chronic, progressive, fibromucinous disorder of unknown etiology, characterized by lichenoid waxy papules and firm induration of skin of trunk, face, forearm and hands; fibroblast proliferation and mucin deposition in the upper ...
Z. Safaii Naraghi.   +1 more
doaj   +2 more sources

Reticular erythematous mucinosis: Relationship between its dermoscopic and histopathological findings

open access: yesClinical Case Reports, 2023
Key Clinical Message In reticular erythematous mucinosis, (1) the presence of dotted vessels and (2) uniform, structureless, yellowish‐white spots, and patches on dermoscopy correspond to histopathological findings of (1) vessels at the tips of the ...
Tomoaki Takada
doaj   +1 more source

Clinical Characteristics, Treatment, and Prognosis of Hydroxychloroquine‐Induced Acute Generalized Exanthematous Pustulosis

open access: yesDermatologic Therapy, Volume 2026, Issue 1, 2026.
Background The clinical characteristics of hydroxychloroquine (HCQ)‐induced acute generalized exanthematous pustulosis (AGEP) remain inadequately defined. This research sought to define the incidence and clinical course of AGEP following HCQ administration.
Fei Lu   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy